Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
13%
Adverse Event
50%
Alendronic Acid
13%
All Cause Mortality
16%
Arterial Thromboembolism
35%
Artery Thrombosis
13%
Asthma
56%
Bisphosphonic Acid Derivative
11%
Chronic Cough
27%
Chronic Depression
13%
Chronic Obstructive Lung Disease
54%
Chronic Pain
13%
Cohort Study
100%
Congestive Heart Failure
13%
COVID-19 Vaccine
12%
Denosumab
11%
Diseases
20%
Disproportionality Analysis
28%
Drug Utilization
28%
Hip Fracture
27%
HIV
27%
Implant
13%
Infection
50%
Inflammatory Arthritis
13%
Isoniazid
27%
Liver Injury
13%
Medication Error
27%
Metoprolol
13%
Monoclonal Antibody
13%
Monotherapy
11%
Muscarinic Receptor Blocking Agent
27%
Non Insulin Dependent Diabetes Mellitus
15%
Nootropic Agent
13%
Observational Study
16%
Parathyroid hormone[1-34]
11%
Pharmacoepidemiology
15%
Polyradiculoneuropathy
13%
Prevalence
22%
Prospective Cohort Study
13%
Ranitidine
13%
Rheumatoid Arthritis
13%
SARS Coronavirus
31%
Standardized Incidence Ratio
15%
Syndrome
27%
Thrombocytopenia
54%
Thromboembolism
38%
Thrombosis
47%
Urine Retention
13%
Vein Thrombosis
17%
Venous Thromboembolism
43%
Medicine and Dentistry
Adverse Event
42%
All Cause Mortality
16%
Asthma
29%
Bronchodilatation
13%
Chronic Cough
27%
Chronic Depression
13%
Chronic Obstructive Pulmonary Disease
27%
Cohort Analysis
58%
Cohort Effect
28%
Congestive Heart Failure
13%
COVID-19 Vaccination
15%
Diseases
30%
Health Outcomes
20%
Hip Fracture
13%
Human Immunodeficiency Virus
27%
Infection
21%
Inflammatory Arthritis
13%
Isoniazid
27%
Liver Injury
13%
Maturity Onset Diabetes of the Young
15%
Medical Device
13%
Medication Error
13%
Medicine
12%
middle age
14%
Monoclonal Antibody
13%
Morphometrics
13%
Muscarinic Antagonist
13%
Nootropic Agent
13%
Observational Study
28%
Odds Ratio
13%
Pancreas Cancer
13%
Parasitic Disease
13%
Patient Characteristics
13%
Patient Referral
15%
Patient with Diabetes
13%
Polyradiculoneuropathy
13%
Pooled Analysis
13%
Prevalence
10%
Primary Health Care
25%
Prospective Cohort Study
13%
Retrospective Cohort Study
17%
Rheumatoid Arthritis
13%
Sarcopenia
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Systemic Immune Inflammation Index
13%
Systemic Lupus Erythematosus
13%
Thrombocytopenia
27%
Thromboembolism
13%
Thrombosis
17%
Venous Thromboembolism
10%